We pursue multiple investment strategies on an opportunistic basis.
AUM: $52.1B · Form ADV, 23 Sep 2026
| i | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| State STR Spdr S&p 500 Etf T | NYSE: SPY | Current | Fund | TR UNIT | -11.2% | $4.0B | -$500M | 17.15% | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| Nasdaq: RVMD | Current | Biological Products, (No Diagnostic Substances) | *W EXP 12/17/202 | 13,538,881 | -132,000 | -1.0% | 6.26% | $2.8B | +$217M | 11.87% | $34.5B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| WBD | Current | COM SER A | 49,372,344 | +49,372,344 | New | $1.5B | +$1.5B | 6.58% | $77.6B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: NTRA | Current | Services-Medical Laboratories | COM | 2,599,648 | +381,282 | +17.2% | 1.79% | $1.1B | +$472M | 4.63% | $42.0B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: BBIO | Current | Pharmaceutical Preparations | COM | 14,247,000 | +3,503,937 | +32.6% | 7.31% | $937M | +$137M | 4.04% | $15.2B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: PTGX | Current | Pharmaceutical Preparations | COM | 6,437,906 | +89,000 | +1.4% | 9.86% | $907M | +$129M | 3.91% | $8.1B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: EXEL | Current | Biological Products, (No Diagnostic Substances) | COM | 14,694,910 | +1,226,900 | +9.1% | 6.02% | $858M | +$126M | 3.70% | $16.1B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: ROIV | Current | Pharmaceutical Preparations | SHS | 21,745,533 | +7,436,533 | +52.0% | 3.00% | $795M | +$289M | 3.43% | $28.2B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Roku, Inc. Class A | Current | COM CL A | 4,160,049 | +4,160,049 | New | $633M | +$633M | 2.73% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||||
| Nasdaq: AMZN | Current | Retail-Catalog & Mail-Order Houses | COM | 2,368,464 | -264,530 | -10.0% | 0.02% | $590M | -$37M | 2.54% | $2.67T | Q3 2026 | 16 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: GRAL | Current | Services-Medical Laboratories | COM | 4,069,233 | -92,351 | -2.2% | 9.05% | $570M | +$286M | 2.46% | $4.5B | Q3 2026 | 16 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: BSX | Current | Surgical & Medical Instruments & Apparatus | COM | 11,287,164 | +765,980 | +7.3% | 0.78% | $493M | +$44M | 2.12% | $62.3B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: AVGO | Current | Semiconductors & Related Devices | COM | 1,395,810 | +244,010 | +21.2% | 0.03% | $490M | +$55M | 2.11% | $1.65T | Q3 2026 | 16 Nov 2026 | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: CRH | Current | ORD | 5,341,100 | +5,341,100 | New | $442M | +$442M | 1.91% | $58.6B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: KVUE | Current | COM | 25,015,000 | +25,015,000 | New | $442M | +$442M | 1.90% | $37.1B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: TWST | Current | Biological Products, (No Diagnostic Substances) | COM | 2,136,400 | 0 | 0.0% | 3.13% | $413M | +$193M | 1.78% | $7.6B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: UNH | Current | Hospital & Medical Service Plans | COM | 1,048,622 | -221,910 | -17.5% | 0.12% | $385M | -$143M | 1.66% | $296B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: MSFT | Current | Services-Prepackaged Software | COM | 733,563 | -379,300 | -34.1% | 0.01% | $376M | -$39M | 1.62% | $3.60T | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Strategy Inc | Nasdaq: MSTR | Current | Finance Services | NOTE 3/0 | +306.4% | $373M | +$281M | 1.61% | $36.5B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: SNPS | Current | Services-Prepackaged Software | COM | 857,890 | +28,290 | +3.4% | 0.45% | $373M | +$3M | 1.61% | $82.6B | Q3 2026 | 16 Nov 2026 | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |
| KKR & Co L P Del | Current | COM | 3,880,020 | -238,280 | -5.8% | $354M | -$24M | 1.53% | Q3 2026 | 16 Nov 2026 | Q4 2025 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: AON | Current | Insurance Agents, Brokers & Service | SHS CL A | 1,239,672 | -142,890 | -10.3% | 0.58% | $343M | -$115M | 1.48% | $70.2B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: LNTH | Current | In Vitro & In Vivo Diagnostic Substances | COM | 3,111,254 | -2,472,225 | -44.3% | 4.76% | $310M | -$310M | 1.33% | $6.7B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: TMO | Current | Measuring & Controlling Devices, NEC | COM | 445,685 | -603,500 | -57.5% | 0.12% | $301M | -$225M | 1.30% | $248B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Liquidia Corp | Nasdaq: LQDA | Current | Pharmaceutical Preparations | COM NEW | 8,906,038 | +541,000 | +6.5% | 9.88% | $269M | -$397M | 1.16% | $5.1B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| NYSE: WAB | Current | Railroad Equipment | COM | 877,903 | -16,600 | -1.9% | 0.52% | $252M | +$11M | 1.09% | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: BEAM | Current | Biological Products, (No Diagnostic Substances) | COM | 10,276,396 | +40,000 | +0.4% | 9.93% | $251M | -$100M | 1.08% | $2.2B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: ARMK | Current | Retail-Eating Places | COM | 4,606,431 | +980,700 | +27.0% | 1.75% | $247M | +$40M | 1.06% | $14.5B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: IMVT | Current | Biological Products, (No Diagnostic Substances) | COM | 6,471,000 | +666,000 | +11.5% | 3.13% | $219M | -$5M | 0.94% | $6.7B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: AGIO | Current | Pharmaceutical Preparations | COM | 5,939,400 | +22,000 | +0.4% | 9.93% | $197M | -$22M | 0.85% | $1.7B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: SMCI | Current | Electronic Computers | NOTE 2.250% 7/1 | New | $158M | +$158M | 0.68% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |||||
| Nasdaq: BIIB | Current | Biological Products, (No Diagnostic Substances) | COM | 680,868 | +609,868 | +859.0% | 0.46% | $154M | +$138M | 0.66% | $36.5B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: JNJ | Current | Pharmaceutical Preparations | COM | 480,426 | +72,426 | +17.8% | 0.02% | $127M | +$24M | 0.55% | $643B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: ACHC | Current | Services-Specialty Outpatient Facilities, NEC | COM | 4,608,400 | +387,600 | +9.2% | 4.96% | $127M | +$2M | 0.55% | $3.2B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: BTSG | Current | Services-Home Health Care Services | COM | 2,043,800 | +311,000 | +17.9% | 1.03% | $116M | -$5M | 0.50% | $12.7B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: TNGX | Current | Pharmaceutical Preparations | COM | 4,550,688 | -7,726,312 | -62.9% | 2.69% | $114M | -$270M | 0.49% | $3.8B | Q3 2026 | 16 Nov 2026 | Q4 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: BIDU | Current | Services-Computer Programming, Data Processing, Etc. | SPON ADR REP A | 1,203,785 | 0 | 0.0% | $105M | -$33M | 0.45% | $22.6B | Q3 2026 | 16 Nov 2026 | Q3 2025 | Q3 2026 | 13F, Q3 2026 | ||
| American Svgs BK Na | ASBH | Current | COM | 4,557,082 | +4,557,082 | New | $82M | +$82M | 0.35% | $1.3B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: PBLS | Current | Pharmaceutical Preparations | COM | 2,368,200 | 0 | 0.0% | $76M | +$12M | 0.33% | $3.5B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||
| ASTRAZENECA PLC | NYSE: AZN | Current | Pharmaceutical Preparations | ORD | 440,000 | -134,000 | -23.3% | $71M | -$38M | 0.31% | $272B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: JOYY | Current | Services-Computer Processing & Data Preparation | ADS REPSTG COM A | 820,200 | +121,000 | +17.3% | $66M | +$20M | 0.28% | $3.6B | Q3 2026 | 16 Nov 2026 | Q1 2025 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: AVTX | Current | Pharmaceutical Preparations | COM NEW | 3,974,000 | +1,476,000 | +59.1% | 6.87% | $61M | +$15M | 0.26% | $390M | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: FRNM | Current | Services-Medical Laboratories | COMMON STOCK | 3,733,757 | +3,733,757 | New | 3.35% | $59M | +$59M | 0.25% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Ionic Digital Inc. | Nasdaq: IOND | Current | Finance Services | COM CL A | 718,123 | +718,123 | New | 1.60% | $58M | +$58M | 0.25% | $2.6B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| Nasdaq: GH | Current | Services-Medical Laboratories | COM | 279,700 | -42,500 | -13.2% | 0.21% | $50M | +$2M | 0.21% | $19.7B | Q3 2026 | 16 Nov 2026 | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |
| Ishares Bitcoin Trust Etf | Nasdaq: IBIT | Current | Commodity Contracts Brokers & Dealers | SHS BEN INT | New | $43M | +$43M | 0.19% | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| ASSEMBLY BIOSCIENCES, INC. | Nasdaq: ASMB | Current | Pharmaceutical Preparations | COM NEW | 1,604,590 | 0 | 0.0% | 7.84% | $38M | -$6M | 0.16% | $461M | Q3 2026 | 16 Nov 2026 | Q3 2025 | Q3 2026 | 13F, Q3 2026 |
| NYSE: NVS | Current | Pharmaceutical Preparations | SPONSORED ADR | 255,000 | -108,000 | -29.8% | $36M | -$21M | 0.16% | $286B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: MAZE | Current | Biological Products, (No Diagnostic Substances) | COM | 1,107,814 | 0 | 0.0% | 2.03% | $30M | -$3M | 0.13% | $1.8B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| LB PHARMACEUTICALS INC | Nasdaq: LBRX | Current | Pharmaceutical Preparations | COM SHS | 741,410 | +741,410 | New | 2.29% | $28M | +$28M | 0.12% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Immunocore Holdings plc | Nasdaq: IMCR | Current | Biological Products, (No Diagnostic Substances) | ADS | 928,000 | +928,000 | New | 1.80% | $28M | +$28M | 0.12% | $1.4B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| Asml Hldg NV | Current | N Y REGISTRY SHS | 13,518 | +13,518 | New | $24M | +$24M | 0.11% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: RIO | Current | Metal Mining | SPONSORED ADR | 218,899 | +35,424 | +19.3% | $21M | +$3M | 0.09% | $121B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: BABA | Current | Services-Business Services, NEC | SPONSORED ADS | 189,000 | +189,000 | New | 0.01% | $20M | +$20M | 0.09% | $207B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: ETRA | Current | Biological Products, (No Diagnostic Substances) | COM | 1,700,000 | +1,700,000 | New | 2.70% | $19M | +$19M | 0.08% | $561M | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Alvotech | Nasdaq: ALVO | Current | Biological Products, (No Diagnostic Substances) | ORDINARY SHARES | 2,859,675 | 0 | 0.0% | $17M | +$6M | 0.07% | $1.5B | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: SUPN | Current | Pharmaceutical Preparations | COM | 447,620 | +447,620 | New | 0.38% | $16M | +$16M | 0.07% | $1.7B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Alamar Biosciences, Inc. | Nasdaq: ALMR | Current | Laboratory Analytical Instruments | COMMON STOCK | 462,900 | 0 | 0.0% | 0.67% | $16M | +$3M | 0.07% | $2.0B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 |
| Nasdaq: NTES | Current | Services-Prepackaged Software | SPONSORED ADS | 123,500 | 0 | 0.0% | $15M | -$0.9M | 0.06% | $67.2B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Latigo Biotherapeutics, Inc. | Nasdaq: LTGO | Current | Pharmaceutical Preparations | COM | 850,000 | +850,000 | New | 1.28% | $14M | +$14M | 0.06% | $878M | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| Nasdaq: ABVX | Current | Pharmaceutical Preparations | SPONSORED ADS | 140,000 | +18,000 | +14.8% | $14M | -$2M | 0.06% | $7.1B | Q3 2026 | 16 Nov 2026 | Q3 2025 | Q3 2026 | 13F, Q3 2026 | ||
| Kailera Therapeutics, Inc. | Nasdaq: KLRA | Current | Pharmaceutical Preparations | COMMON STOCK | 1,100,000 | 0 | 0.0% | 0.85% | $13M | -$12M | 0.05% | $1.5B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 |
| ENANTA PHARMACEUTICALS INC | Nasdaq: ENTA | Current | Pharmaceutical Preparations | COM | 950,000 | -1,468,202 | -60.7% | 3.26% | $13M | -$23M | 0.05% | $232M | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 |
| VNET Group, Inc. | Nasdaq: VNET | Current | Services-Computer Programming, Data Processing, Etc. | SPONSORED ADS A | 2,025,000 | +33,000 | +1.7% | $11M | -$52M | 0.05% | $625M | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: TSHA | Current | Biological Products, (No Diagnostic Substances) | COM SHS | 2,249,000 | -1,000 | -0.0% | 0.69% | $11M | -$4M | 0.05% | $1.2B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: NERV | Current | Pharmaceutical Preparations | COM NEW | 2,365,000 | 0 | 0.0% | 4.75% | $8M | -$5M | 0.03% | $106M | Q3 2026 | 16 Nov 2026 | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: SCTX | Current | Biological Products, (No Diagnostic Substances) | COM | 380,000 | +380,000 | New | 2.01% | $7M | +$7M | 0.03% | $250M | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| COHU INC | Nasdaq: COHU | Current | Instruments For Meas & Testing of Electricity & Elec Signals | COM | 91,000 | +91,000 | New | 0.19% | $6M | +$6M | 0.03% | $1.9B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| Inflarx NV | Current | COM | 3,310,000 | -15,000 | -0.5% | $6M | -$1M | 0.03% | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||||
| Nasdaq: ENTG | Current | Plastics Products, NEC | COM | 37,000 | +37,000 | New | 0.02% | $6M | +$6M | 0.02% | $21.1B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| Braveheart Bio, Inc. | Nasdaq: BRVE | Current | Pharmaceutical Preparations | COM SHS | 277,778 | +277,778 | New | 0.31% | $6M | +$6M | 0.02% | $1.6B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| NYSE: CLS | Current | Printed Circuit Boards | COM | 15,000 | +15,000 | New | 0.01% | $5M | +$5M | 0.02% | $30.3B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| REVVITY, INC. | NYSE: RVTY | Current | Laboratory Analytical Instruments | COM | 35,000 | +35,000 | New | 0.03% | $5M | +$5M | 0.02% | $16.9B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| NYSE: VEEV | Current | Services-Prepackaged Software | CL A COM | 18,500 | +18,500 | New | 0.01% | $5M | +$5M | 0.02% | $42.6B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| ROCKWELL AUTOMATION, INC | NYSE: ROK | Current | Measuring & Controlling Devices, NEC | COM | 12,000 | +12,000 | New | 0.01% | $5M | +$5M | 0.02% | $42.0B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| Gates Industrial Corp Ltd. | NYSE: GTES | Current | General Industrial Machinery & Equipment | COM SHS | 196,000 | +196,000 | New | 0.08% | $5M | +$5M | 0.02% | $6.0B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| McGraw Hill, Inc. | NYSE: MH | Current | Miscellaneous Publishing | COM | 389,000 | +389,000 | New | 0.20% | $5M | +$5M | 0.02% | $2.3B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| NYSE: ECL | Current | Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics | COM | 18,500 | +18,500 | New | 0.01% | $5M | +$5M | 0.02% | $83.4B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: WOR | Current | Steel Works, Blast Furnaces & Rolling & Finishing Mills | COM | 85,000 | +85,000 | New | 0.17% | $5M | +$5M | 0.02% | $2.8B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: ATI | Current | Steel Pipe & Tubes | COM | 26,500 | +26,500 | New | 0.02% | $5M | +$5M | 0.02% | $23.7B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: BLDR | Current | Retail-Lumber & Other Building Materials Dealers | COM | 87,000 | +87,000 | New | 0.08% | $5M | +$5M | 0.02% | $6.0B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: NKE | Current | Rubber & Plastics Footwear | CL B | 140,000 | +140,000 | New | $5M | +$5M | 0.02% | $48.9B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: RPM | Current | Paints, Varnishes, Lacquers, Enamels & Allied Prods | COM | 50,000 | +50,000 | New | 0.04% | $5M | +$5M | 0.02% | $13.2B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| ENERGY CO OF PARANA | NYSE: ELPC | Current | Electric Services | SPONSORED ADS | 395,000 | +395,000 | New | $5M | +$5M | 0.02% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: MGA | Current | Motor Vehicle Parts & Accessories | COM | 77,000 | +77,000 | New | $5M | +$5M | 0.02% | $15.9B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: WDS | Current | Crude Petroleum & Natural Gas | SPONSORED ADR | 220,000 | +220,000 | New | $5M | +$5M | 0.02% | $38.1B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: MOD | Current | Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip | COM | 26,000 | +26,000 | New | 0.05% | $5M | +$5M | 0.02% | $7.2B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: FDS | Current | Services-Computer Programming, Data Processing, Etc. | COM | 18,000 | +18,000 | New | 0.05% | $5M | +$5M | 0.02% | $10.9B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nextpower | Nasdaq: NXT | Current | Semiconductors & Related Devices | COM | 62,000 | +62,000 | New | 0.04% | $5M | +$5M | 0.02% | $11.6B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| Vesta Real Estate Corporation, S.A.B. de C.V. | NYSE: VTMX | Current | Real Estate | ADS | 150,000 | +150,000 | New | $5M | +$5M | 0.02% | $3.2B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: EXPD | Current | Arrangement of Transportation of Freight & Cargo | COM | 26,000 | +26,000 | New | 0.02% | $5M | +$5M | 0.02% | $24.9B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: GXO | Current | Transportation Services | COMMON STOCK | 108,000 | +108,000 | New | 0.10% | $5M | +$5M | 0.02% | $6.1B | Q3 2026 | 16 Nov 2026 | Q4 2024 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: KBR | Current | Heavy Construction Other Than Bldg Const - Contractors | COM | 136,000 | +136,000 | New | 0.11% | $5M | +$5M | 0.02% | $4.0B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Nasdaq: FLEX | Current | Printed Circuit Boards | ORD | 43,000 | +43,000 | New | 0.01% | $5M | +$5M | 0.02% | $24.5B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |
| Guidewire Software | NYSE: GWRE | Current | Services-Prepackaged Software | COM | 33,000 | +33,000 | New | 0.04% | $5M | +$5M | 0.02% | $11.1B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 |
| NYSE: KHC | Current | Canned, Frozen & Preservd Fruit, Veg & Food Specialties | COM | 206,000 | +206,000 | New | 0.02% | $5M | +$5M | 0.02% | $30.1B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| NYSE: BVN | Current | Metal Mining | SPONSORED ADR | 148,000 | +148,000 | New | $5M | +$5M | 0.02% | $5.4B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| NYSE: LMND | Current | Fire, Marine & Casualty Insurance | COM | 103,000 | +103,000 | New | 0.13% | $5M | +$5M | 0.02% | $3.0B | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |
| Telix Pharmaceuticals Ltd | Nasdaq: TLX | Current | Pharmaceutical Preparations | SPONSORED ADS | 419,000 | +419,000 | New | $5M | +$5M | 0.02% | Q3 2026 | 16 Nov 2026 | Q3 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Mobia Medical, Inc. | Nasdaq: MOBI | Current | Surgical & Medical Instruments & Apparatus | COMMON STOCK | 437,828 | -690,729 | -61.2% | 1.31% | $4M | -$11M | 0.02% | $395M | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q3 2026 | 13F, Q3 2026 |
| Exited | COM | 0 | -7,919,500 | -100.0% | -$1.6B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | |||||||
| Hess Corp | Exited | COM | 0 | -5,805,000 | -100.0% | -$804M | Q3 2025 | 14 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Invesco Exchange Traded FD T | Exited | Fund | S&P500 EQL WGT | -100.0% | -$691M | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | |||||||
| Ishares TR | Exited | Fund | IBOXX HI YD ETF | -100.0% | -$645M | Q1 2026 | 15 May 2026 | Q2 2025 | Q4 2025 | 13F, Q4 2025 | |||||||
| Autodesk, Inc. | Nasdaq: ADSK | Exited | Services-Prepackaged Software | COM | 0 | -1,662,852 | -100.0% | -$528M | $50.9B | Q4 2025 | 17 Feb 2026 | Q4 2024 | Q3 2025 | 13F, Q3 2025 | |||
| Cyberark Software Ltd | Exited | SHS | 0 | -1,053,040 | -100.0% | -$470M | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||||
| Intra-Cellular Therapies Inc | Exited | COM | 0 | -3,055,000 | -100.0% | -$403M | Q2 2025 | 14 Aug 2025 | Q1 2025 | Q1 2025 | 13F, Q1 2025 | ||||||
| Eli Lilly | NYSE: LLY | Exited | Pharmaceutical Preparations | COM | -100.0% | -$403M | $1.20T | Q1 2026 | 15 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | |||||
| NYSE: SCHW | Exited | Security Brokers, Dealers & Flotation Companies | COM | 0 | -3,955,657 | -100.0% | -$372M | $159B | Q2 2026 | 14 Aug 2026 | Q4 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| ANSYS Inc | Exited | COM | 0 | -997,128 | -100.0% | -$350M | Q3 2025 | 14 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Crinetics Pharmaceuticals Inc | Exited | COM | 0 | -8,989,098 | -100.0% | -$336M | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q2 2026 | 13F, Q2 2026 | ||||||
| NYSE: CRM | Exited | Services-Prepackaged Software | COM | 0 | -1,261,177 | -100.0% | -$334M | $151B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: INTU | Exited | Services-Prepackaged Software | COM | 0 | -488,088 | -100.0% | -$333M | $72.3B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Kellanova | Exited | COM | 0 | -3,943,853 | -100.0% | -$323M | Q4 2025 | 17 Feb 2026 | Q3 2025 | Q3 2025 | 13F, Q3 2025 | ||||||
| ANALOG DEVICES INC | Nasdaq: ADI | Exited | Semiconductors & Related Devices | COM | 0 | -1,299,500 | -100.0% | -$319M | $183B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | |||
| Nasdaq: ABNB | Exited | Services-To Dwellings & Other Buildings | COM CL A | 0 | -2,429,200 | -100.0% | -$319M | $103B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| NASDAQ, INC. | Nasdaq: NDAQ | Exited | Security & Commodity Brokers, Dealers, Exchanges & Services | COM | 0 | -2,989,213 | -100.0% | -$290M | $57.7B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | |||
| Nasdaq: GOOGL | Exited | Services-Computer Programming, Data Processing, Etc. | CAP STK CL C | 0 | -996,231 | -100.0% | -$286M | $3.25T | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: V | Exited | Services-Business Services, NEC | COM CL A | 0 | -840,710 | -100.0% | -$254M | $750B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: DIS | Exited | Services-Miscellaneous Amusement & Recreation | COM | 0 | -2,401,591 | -100.0% | -$231M | $197B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: NYT | Exited | Newspapers: Publishing or Publishing & Printing | CL A | 0 | -3,280,678 | -100.0% | -$228M | $11.0B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| NYSE: MA | Exited | Services-Business Services, NEC | CL A | 0 | -435,071 | -100.0% | -$217M | $545B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: SHW | Exited | Retail-Building Materials, Hardware, Garden Supply | COM | 0 | -555,950 | -100.0% | -$212M | $82.1B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| NYSE: MCK | Exited | Wholesale-Drugs, Proprietaries & Druggists' Sundries | COM | 0 | -234,300 | -100.0% | -$203M | $123B | Q2 2026 | 14 Aug 2026 | Q4 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Dayforce Inc | Exited | COM | 0 | -2,925,000 | -100.0% | -$202M | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||||
| Stericycle Inc | Exited | COM | 0 | -3,146,000 | -100.0% | -$192M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| Centessa Pharmaceuticals PLC | Exited | SPONSORED ADS | 0 | -4,809,000 | -100.0% | -$191M | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||||
| Southwestern Energy Co | Exited | COM | 0 | -25,993,099 | -100.0% | -$185M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| NYSE: NSC | Exited | Railroads, Line-Haul Operating | COM | 0 | -615,000 | -100.0% | -$185M | $71.2B | Q4 2025 | 17 Feb 2026 | Q3 2025 | Q3 2025 | 13F, Q3 2025 | ||||
| NYSE: BMY | Exited | Pharmaceutical Preparations | COM | 0 | -3,188,000 | -100.0% | -$180M | $119B | Q1 2025 | 15 May 2025 | Q4 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| NYSE: IQV | Exited | Services-Commercial Physical & Biological Research | COM | 0 | -938,551 | -100.0% | -$178M | $41.3B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Verona Pharma PLC | Exited | SPONSORED ADS | 0 | -1,810,000 | -100.0% | -$171M | Q3 2025 | 14 Nov 2025 | Q1 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Azek Co Inc | Exited | CL A | 0 | -3,141,400 | -100.0% | -$171M | Q3 2025 | 14 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| CBRE GROUP, INC. | NYSE: CBRE | Exited | Real Estate | CL A | 0 | -983,771 | -100.0% | -$158M | $37.0B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | |||
| Nasdaq: WWD | Exited | Electrical Industrial Apparatus | COM | 0 | -621,973 | -100.0% | -$157M | $19.8B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| NYSE: HWM | Exited | Rolling Drawing & Extruding of Nonferrous Metals | COM | 0 | -1,514,339 | -100.0% | -$152M | $86.8B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| Nasdaq: SRPT | Exited | Pharmaceutical Preparations | COM | 0 | -2,341,424 | -100.0% | -$149M | $1.5B | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| Nasdaq: TYRA | Exited | Pharmaceutical Preparations | COM | 0 | -3,580,818 | -100.0% | -$137M | $1.4B | Q2 2026 | 14 Aug 2026 | Q4 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Squarespace Inc | Exited | CLASS A | 0 | -2,891,632 | -100.0% | -$134M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| NYSE: NVO | Exited | Pharmaceutical Preparations | ADR | 0 | -2,619,000 | -100.0% | -$126M | $171B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| NYSE: BHVN | Exited | Pharmaceutical Preparations | COM | 0 | -4,813,167 | -100.0% | -$116M | $2.1B | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| Hims & Hers Health, Inc. | NYSE: HIMS | Exited | Services-Offices & Clinics of Doctors of Medicine | COM CL A | 0 | -3,386,986 | -100.0% | -$110M | $3.8B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | |||
| Nasdaq: MRNA | Exited | Biological Products, (No Diagnostic Substances) | COM | -100.0% | -$109M | $80.7B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||||
| Championx Corporation | Exited | COM | 0 | -4,245,000 | -100.0% | -$105M | Q3 2025 | 14 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Longboard Pharmaceuticals In | Exited | COM | 0 | -3,150,857 | -100.0% | -$105M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| Nasdaq: GEHC | Exited | X-Ray Apparatus & Tubes & Related Irradiation Apparatus | COMMON STOCK | 0 | -1,322,000 | -100.0% | -$98M | $37.0B | Q3 2025 | 14 Nov 2025 | Q4 2024 | Q2 2025 | 13F, Q2 2025 | ||||
| KE Holdings Inc. | NYSE: BEKE | Exited | Real Estate Agents & Managers (For Others) | SPONSORED ADS | 0 | -4,740,833 | -100.0% | -$94M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| Nasdaq: RUN | Exited | Construction - Special Trade Contractors | NOTE 2/0 | -100.0% | -$94M | $1.7B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| NYSE: THC | Exited | Services-General Medical & Surgical Hospitals, NEC | COM NEW | 0 | -452,153 | -100.0% | -$85M | $21.0B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Cidara Therapeutics, Inc. | Exited | COM NEW | 0 | -382,800 | -100.0% | -$85M | Q1 2026 | 15 May 2026 | Q2 2025 | Q4 2025 | 13F, Q4 2025 | ||||||
| Ishares TR | Exited | Fund | ISHARES SEMICDTR | -100.0% | -$83M | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q2 2026 | 13F, Q2 2026 | |||||||
| NYSE: SGI | Exited | Household Furniture | COM | 0 | -1,326,242 | -100.0% | -$79M | $13.7B | Q2 2025 | 14 Aug 2025 | Q1 2025 | Q1 2025 | 13F, Q1 2025 | ||||
| Cardinal Health | NYSE: CAH | Exited | Wholesale-Drugs, Proprietaries & Druggists' Sundries | COM | 0 | -368,000 | -100.0% | -$78M | $62.9B | Q2 2026 | 14 Aug 2026 | Q1 2025 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: PCVX | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -1,261,000 | -100.0% | -$73M | $9.2B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Dianthus Therapeutics, Inc. /DE/ | Nasdaq: DNTH | Exited | Pharmaceutical Preparations | COM | 0 | -836,000 | -100.0% | -$70M | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: MARA | Exited | Finance Services | COM | 0 | -3,660,000 | -100.0% | -$67M | $2.4B | Q4 2025 | 17 Feb 2026 | Q4 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Masimo Corp | Exited | COM | 0 | -397,000 | -100.0% | -$66M | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||||
| Nasdaq: ICLR | Exited | Services-Commercial Physical & Biological Research | SHS | 0 | -220,800 | -100.0% | -$63M | $14.3B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| TransUnion | NYSE: TRU | Exited | Services-Consumer Credit Reporting, Collection Agencies | COM | 0 | -675,000 | -100.0% | -$58M | $14.2B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | |||
| Healthcare Realty Trust Inc | NYSE: HR | Exited | Real Estate Investment Trusts | CL A COM | 0 | -3,264,000 | -100.0% | -$55M | $6.7B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | |||
| NYSE: ZTO | Exited | Trucking & Courier Services (No Air) | NOTE 1.500% 9/0 | -100.0% | -$55M | $15.3B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||||
| Liberty Broadband Corp | Exited | COM SER C | 0 | -660,000 | -100.0% | -$51M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| Grayscale Coindesk Crypto | Exited | USD SHS | 0 | -851,193 | -100.0% | -$48M | Q4 2025 | 17 Feb 2026 | Q3 2025 | Q3 2025 | 13F, Q3 2025 | ||||||
| MR Cooper Group Inc | Exited | COM | 0 | -222,000 | -100.0% | -$47M | Q4 2025 | 17 Feb 2026 | Q2 2025 | Q3 2025 | 13F, Q3 2025 | ||||||
| NYSE: CNC | Exited | Hospital & Medical Service Plans | COM | 0 | -614,917 | -100.0% | -$46M | $32.5B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| Nasdaq: NKTR | Exited | Pharmaceutical Preparations | COM NEW | 0 | -791,000 | -100.0% | -$45M | $1.1B | Q4 2025 | 17 Feb 2026 | Q3 2025 | Q3 2025 | 13F, Q3 2025 | ||||
| Nasdaq: INSM | Exited | Pharmaceutical Preparations | COM PAR $.01 | 0 | -3,000 | -100.0% | -$44M | $31.7B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: JD | Exited | Retail-Retail Stores, NEC | NOTE 0.250% 6/0 | -100.0% | -$42M | $34.6B | Q3 2025 | 14 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Verve Therapeutics Inc | Exited | COM | 0 | -3,612,000 | -100.0% | -$41M | Q3 2025 | 14 Nov 2025 | Q1 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Nasdaq: ALNY | Exited | Pharmaceutical Preparations | COM | -100.0% | -$40M | $19.8B | Q1 2026 | 15 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | ||||||
| Flutter Entmt PLC | Exited | SHS | 0 | -137,369 | -100.0% | -$35M | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||||
| Ishares Ethereum TR | Exited | Fund | SHS | 0 | -1,481,001 | -100.0% | -$33M | Q1 2026 | 15 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | |||||
| Uniqure NV | Exited | SHS | 0 | -565,000 | -100.0% | -$33M | Q4 2025 | 17 Feb 2026 | Q1 2025 | Q3 2025 | 13F, Q3 2025 | ||||||
| Nasdaq: RARE | Exited | Pharmaceutical Preparations | COM | 0 | -898,000 | -100.0% | -$33M | $1.8B | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||
| Nasdaq: GPCR | Exited | Pharmaceutical Preparations | SPONSORED ADS | 0 | -454,000 | -100.0% | -$32M | $1.2B | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: MLYS | Exited | Pharmaceutical Preparations | COM | 0 | -823,296 | -100.0% | -$30M | $1.3B | Q1 2026 | 15 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| SunocoCorp LLC | TXSE: SUNC | Exited | Petroleum Refining | COM SHS LLC | 0 | -606,277 | -100.0% | -$30M | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: CGON | Exited | Biological Products, (No Diagnostic Substances) | COM | -100.0% | -$28M | $7.3B | Q3 2026 | 16 Nov 2026 | Q2 2025 | Q2 2026 | 13F, Q2 2026 | ||||||
| DBX Etf TR | Exited | Fund | XTRACK HRVST CSI | -100.0% | -$27M | Q1 2025 | 15 May 2025 | Q4 2024 | Q4 2024 | 13F, Q4 2024 | |||||||
| Bitwise 10 Crypto Index Etf | NYSE: BITW | Exited | Commodity Contracts Brokers & Dealers | UNIT BENEFICIAL | 0 | -603,000 | -100.0% | -$27M | Q2 2026 | 14 Aug 2026 | Q4 2025 | Q1 2026 | 13F, Q1 2026 | ||||
| Terns Pharmaceuticals Inc | Exited | COM | 0 | -642,000 | -100.0% | -$26M | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||||
| NYSE: MRK | Exited | Pharmaceutical Preparations | COM | 0 | -199,000 | -100.0% | -$26M | $327B | Q3 2026 | 16 Nov 2026 | Q1 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| Warby Parker Inc. | NYSE: WRBY | Exited | Ophthalmic Goods | CL A COM | 0 | -828,000 | -100.0% | -$25M | $3.0B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | |||
| NYSE: EHC | Exited | Services-Hospitals | COM | 0 | -234,500 | -100.0% | -$25M | $13.0B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Perceptive Cap Solutions Cor | Exited | CL A ORD SHS | 0 | -2,250,000 | -100.0% | -$24M | Q3 2026 | 16 Nov 2026 | Q4 2025 | Q2 2026 | 13F, Q2 2026 | ||||||
| Nasdaq: RPRX | Exited | Pharmaceutical Preparations | SHS CLASS A | 0 | -493,000 | -100.0% | -$24M | $38.9B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: SGRY | Exited | Services-General Medical & Surgical Hospitals, NEC | COM | 0 | -871,830 | -100.0% | -$19M | $3.5B | Q4 2025 | 17 Feb 2026 | Q2 2025 | Q3 2025 | 13F, Q3 2025 | ||||
| NYSE: ABT | Exited | Pharmaceutical Preparations | COM | 0 | -136,000 | -100.0% | -$18M | $180B | Q3 2025 | 14 Nov 2025 | Q1 2025 | Q2 2025 | 13F, Q2 2025 | ||||
| NYSE: YMM | Exited | Services-Prepackaged Software | SPONSORED ADS | 0 | -1,550,598 | -100.0% | -$18M | $9.5B | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||
| Evolent Health, Inc. | NYSE: EVH | Exited | Services-Management Services | CL A | 0 | -639,000 | -100.0% | -$18M | $388M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | |||
| Paramount Global | Exited | CLASS B COM | 0 | -1,346,151 | -100.0% | -$17M | Q3 2025 | 14 Nov 2025 | Q2 2025 | Q2 2025 | 13F, Q2 2025 | ||||||
| Axalta Coating Sys Ltd | Exited | COM | 0 | -478,000 | -100.0% | -$16M | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | ||||||
| NYSE: TAL | Exited | Services-Educational Services | SPONSORED ADS | 0 | -1,365,000 | -100.0% | -$16M | $5.6B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| Nasdaq: VSTM | Exited | Pharmaceutical Preparations | COM NEW | 0 | -2,000,000 | -100.0% | -$15M | $864M | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: AMGN | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -47,000 | -100.0% | -$15M | $237B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| CECO ENVIRONMENTAL CORP | TXSE: CECO | Exited | Industrial & Commercial Fans & Blowers & Air Purifing Equip | COM | 0 | -234,000 | -100.0% | -$14M | $3.0B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | |||
| NYSE: DOCS | Exited | Services-Computer Programming Services | CL A | 0 | -311,000 | -100.0% | -$14M | $5.3B | Q1 2026 | 15 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| LATAM AIRLINES GROUP S.A. | NYSE: LTM | Exited | Air Transportation, Scheduled | SPONSORED ADR | 0 | -318,092 | -100.0% | -$13M | $12.9B | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | |||
| GDS Holdings Ltd | Nasdaq: GDS | Exited | Services-Computer Programming, Data Processing, Etc. | SPONSORED ADS | 0 | -292,000 | -100.0% | -$12M | $3.0B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | |||
| Nuvalent Inc | Exited | COM | 0 | -150,000 | -100.0% | -$11M | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||||
| Medline Inc. | Nasdaq: MDLN | Exited | Surgical & Medical Instruments & Apparatus | COM CL A | 0 | -260,000 | -100.0% | -$11M | $49.8B | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | |||
| New Oriental Ed & Technology | Exited | SPON ADR | 0 | -196,000 | -100.0% | -$11M | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||||
| Nasdaq: NTLA | Exited | In Vitro & In Vivo Diagnostic Substances | COM | 0 | -607,200 | -100.0% | -$10M | $1.3B | Q4 2025 | 17 Feb 2026 | Q3 2025 | Q3 2025 | 13F, Q3 2025 | ||||
| Soleno Therapeutics Inc | Exited | COM | 0 | -153,000 | -100.0% | -$10M | Q4 2025 | 17 Feb 2026 | Q4 2024 | Q3 2025 | 13F, Q3 2025 | ||||||
| Tectonic Therapeutic, Inc. | Nasdaq: TECX | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -640,000 | -100.0% | -$10M | $411M | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | |||
| Nasdaq: BBNX | Exited | Surgical & Medical Instruments & Apparatus | COM | 0 | -595,000 | -100.0% | -$9M | $724M | Q3 2026 | 16 Nov 2026 | Q1 2025 | Q2 2026 | 13F, Q2 2026 | ||||
| GeneDx Holdings Corp. | Nasdaq: WGS | Exited | Services-Health Services | COM CL A | 0 | -70,000 | -100.0% | -$9M | $1.5B | Q1 2026 | 15 May 2026 | Q4 2024 | Q4 2025 | 13F, Q4 2025 | |||
| Nasdaq: SVRA | Exited | Pharmaceutical Preparations | COM | 0 | -2,500,000 | -100.0% | -$9M | $1.1B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Ventyx Biosciences Inc | Exited | COM | 0 | -3,170,000 | -100.0% | -$7M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| TransMedics Group, Inc. | Nasdaq: TMDX | Exited | Electromedical & Electrotherapeutic Apparatus | COM | 0 | -44,000 | -100.0% | -$7M | $3.3B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | |||
| Grayscale Ethereum Mini TR E | NYSE: ETH | Exited | Commodity Contracts Brokers & Dealers | SHS NEW | 0 | -228,340 | -100.0% | -$6M | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Helix Acquisition Corp Ii | Exited | CL A ORD SHS | 0 | -600,000 | -100.0% | -$6M | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||||
| Nasdaq: ANAB | Exited | Pharmaceutical Preparations | COM | 0 | -183,876 | -100.0% | -$6M | $1.4B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| NYSE: SMG | Exited | Agricultural Chemicals | CL A | 0 | -88,000 | -100.0% | -$6M | $3.6B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| Nasdaq: FORM | Exited | Semiconductors & Related Devices | COM | 0 | -56,500 | -100.0% | -$5M | $6.4B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: MTZ | Exited | Water, Sewer, Pipeline, Comm & Power Line Construction | COM | 0 | -17,000 | -100.0% | -$5M | $13.2B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: WAY | Exited | Services-Computer Integrated Systems Design | COM | 0 | -264,900 | -100.0% | -$5M | $5.2B | Q3 2026 | 16 Nov 2026 | Q4 2024 | Q2 2026 | 13F, Q2 2026 | ||||
| Nasdaq: CYTK | Exited | Pharmaceutical Preparations | COM NEW | 0 | -102,400 | -100.0% | -$5M | $7.2B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| Nasdaq: DYN | Exited | Pharmaceutical Preparations | COM | 0 | -229,121 | -100.0% | -$5M | $3.0B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| NYSE: C | Exited | National Commercial Banks | COM NEW | 0 | -47,000 | -100.0% | -$5M | $183B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Springworks Therapeutics Inc | Exited | COM | 0 | -118,000 | -100.0% | -$5M | Q2 2025 | 14 Aug 2025 | Q1 2025 | Q1 2025 | 13F, Q1 2025 | ||||||
| Hyatt Hotels | NYSE: H | Exited | Hotels & Motels | COM CL A | 0 | -36,000 | -100.0% | -$5M | $17.4B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | |||
| NYSE: WAL | Exited | State Commercial Banks | COM | 0 | -73,000 | -100.0% | -$5M | $7.5B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: BC | Exited | Engines & Turbines | COM | 0 | -61,000 | -100.0% | -$5M | $4.7B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| NYSE: TKR | Exited | Ball & Roller Bearings | COM | 0 | -51,000 | -100.0% | -$5M | $7.1B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: SPGI | Exited | Services-Consumer Credit Reporting, Collection Agencies | COM | 0 | -12,000 | -100.0% | -$5M | $127B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| LITTELFUSE INC /DE | Nasdaq: LFUS | Exited | Switchgear & Switchboard Apparatus | COM | 0 | -15,000 | -100.0% | -$5M | $9.8B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | |||
| NYSE: PIPR | Exited | Security Brokers, Dealers & Flotation Companies | COM NEW | 0 | -66,000 | -100.0% | -$5M | $4.4B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: AIR | Exited | Aircraft & Parts | COM | 0 | -46,000 | -100.0% | -$5M | $4.2B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: GNTX | Exited | Motor Vehicle Parts & Accessories | COM | 0 | -199,000 | -100.0% | -$5M | $3.9B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| Nasdaq: GTX | Exited | Motor Vehicle Parts & Accessories | COM | 0 | -275,000 | -100.0% | -$5M | $4.0B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Allete Inc | Exited | COM NEW | 0 | -75,000 | -100.0% | -$5M | Q4 2025 | 17 Feb 2026 | Q3 2025 | Q3 2025 | 13F, Q3 2025 | ||||||
| NYSE: ROL | Exited | Services-To Dwellings & Other Buildings | COM | 0 | -93,000 | -100.0% | -$5M | $18.2B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: AFRM | Exited | Personal Credit Institutions | COM CL A | 0 | -108,000 | -100.0% | -$5M | $19.3B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: INTR | Exited | Commercial Banks, NEC | CLASS A COM | 0 | -614,500 | -100.0% | -$5M | $1.6B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| CUMMINS INC | NYSE: CMI | Exited | Engines & Turbines | COM | 0 | -9,000 | -100.0% | -$5M | $57.7B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: FISV | Exited | Services-Business Services, NEC | COM | 0 | -86,000 | -100.0% | -$5M | $30.1B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: ZYME | Exited | Pharmaceutical Preparations | COM | 0 | -400,000 | -100.0% | -$5M | $1.9B | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| NYSE: VRT | Exited | Electronic Components, NEC | COM CL A | 0 | -19,000 | -100.0% | -$5M | $71.2B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: IDXX | Exited | In Vitro & In Vivo Diagnostic Substances | COM | 0 | -9,000 | -100.0% | -$5M | $53.3B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| Nasdaq: AMKR | Exited | Semiconductors & Related Devices | COM | 0 | -104,000 | -100.0% | -$5M | $8.5B | Q2 2026 | 14 Aug 2026 | Q4 2025 | Q1 2026 | 13F, Q1 2026 | ||||
| Atrium Therapeutics, Inc. | Nasdaq: RNA | Exited | Pharmaceutical Preparations | COM | 0 | -349,360 | -100.0% | -$5M | $151M | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: GFS | Exited | Semiconductors & Related Devices | ORDINARY SHARES | 0 | -105,000 | -100.0% | -$5M | $21.7B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| NYSE: MOH | Exited | Hospital & Medical Service Plans | COM | 0 | -35,000 | -100.0% | -$5M | $10.6B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Opus Genetics, Inc. | Nasdaq: IRD | Exited | Pharmaceutical Preparations | COM | 0 | -1,000,000 | -100.0% | -$5M | $394M | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: TENB | Exited | Services-Prepackaged Software | COM | 0 | -265,000 | -100.0% | -$4M | $4.6B | Q2 2026 | 14 Aug 2026 | Q1 2026 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: RXST | Exited | Ophthalmic Goods | COM | 0 | -175,000 | -100.0% | -$4M | $193M | Q2 2025 | 14 Aug 2025 | Q1 2025 | Q1 2025 | 13F, Q1 2025 | ||||
| ServiceNow | NYSE: NOW | Exited | Services-Prepackaged Software | COM | 0 | -41,000 | -100.0% | -$4M | $92.2B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | |||
| NYSE: CMC | Exited | Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens) | COM | 0 | -67,000 | -100.0% | -$4M | $6.3B | Q3 2026 | 16 Nov 2026 | Q2 2026 | Q2 2026 | 13F, Q2 2026 | ||||
| NYSE: OSCR | Exited | Hospital & Medical Service Plans | CL A | 0 | -264,000 | -100.0% | -$4M | $8.1B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: AMLX | Exited | Pharmaceutical Preparations | COM | 0 | -1,150,221 | -100.0% | -$4M | $3.4B | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||
| NYSE: GRND | Exited | Services-Computer Programming, Data Processing, Etc. | *W EXP 11/18/202 | 0 | -540,000 | -100.0% | -$4M | $2.5B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| Mac Copper Limited | Exited | ORD SHS | 0 | -330,901 | -100.0% | -$4M | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||||
| Swiftmerge Acquisition Corp | Exited | CLASS A ORD SHS | 0 | -1,290,000 | -100.0% | -$3M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||||||
| Metagenomi Therapeutics, Inc. | Nasdaq: MGX | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -1,057,201 | -100.0% | -$2M | $23M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | |||
| Nasdaq: VYGR | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -715,000 | -100.0% | -$2M | $100M | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||
| Exited | COM | 0 | -32,000 | -100.0% | -$2M | Q4 2024 | 14 Feb 2025 | Q3 2024 | Q3 2024 | 13F, Q3 2024 | |||||||
| Elevation Oncology Inc | Exited | COM | 0 | -3,527,482 | -100.0% | -$2M | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||||
| Marblegate Acquisition Corp | Exited | *W EXP 08/31/202 | 0 | -1,635,000 | -100.0% | -$2M | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||||
| Nasdaq: MDGL | Exited | Pharmaceutical Preparations | COM | 0 | -3,319 | -100.0% | -$2M | $9.2B | Q2 2026 | 14 Aug 2026 | Q3 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Tvardi Therapeutics, Inc. | Nasdaq: TVRD | Exited | Pharmaceutical Preparations | COM | 0 | -43,225 | -100.0% | -$2M | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Nasdaq: SIMO | Exited | Semiconductors & Related Devices | SPONSORED ADR | 0 | -29,298 | -100.0% | -$1M | $4.9B | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| Teva Pharmaceutical Industries | Exited | SPONSORED ADS | 0 | -40,000 | -100.0% | -$1M | Q3 2026 | 16 Nov 2026 | Q3 2025 | Q2 2026 | 13F, Q2 2026 | ||||||
| Nasdaq: NVAX | Exited | Biological Products, (No Diagnostic Substances) | COM NEW | 0 | -195,000 | -100.0% | -$1M | $1.3B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: SDGR | Exited | Pharmaceutical Preparations | COM | 0 | -71,000 | -100.0% | -$1M | $2.0B | Q1 2026 | 15 May 2026 | Q2 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: CAPR | Exited | Pharmaceutical Preparations | COM NEW | 0 | -41,000 | -100.0% | -$1M | $438M | Q2 2026 | 14 Aug 2026 | Q4 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| BIODESIX INC | Nasdaq: BDSX | Exited | Services-Medical Laboratories | COM | 0 | -1,859,308 | -100.0% | -$1M | $92M | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | |||
| Nasdaq: JANX | Exited | Pharmaceutical Preparations | COM | 0 | -48,000 | -100.0% | -$1M | $630M | Q3 2025 | 14 Nov 2025 | Q4 2024 | Q2 2025 | 13F, Q2 2025 | ||||
| Nasdaq: ARWR | Exited | Pharmaceutical Preparations | COM | 0 | -15,800 | -100.0% | -$1.0M | $6.2B | Q2 2026 | 14 Aug 2026 | Q4 2024 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: ARQT | Exited | Pharmaceutical Preparations | COM | 0 | -26,000 | -100.0% | -$0.8M | $3.4B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: ALKS | Exited | Pharmaceutical Preparations | SHS | 0 | -20,800 | -100.0% | -$0.7M | $7.8B | Q2 2026 | 14 Aug 2026 | Q1 2025 | Q1 2026 | 13F, Q1 2026 | ||||
| Nasdaq: AXSM | Exited | Pharmaceutical Preparations | COM | 0 | -4,000 | -100.0% | -$0.7M | $7.1B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Forte Biosciences Inc. | Exited | COM NEW | 0 | -70,429 | -100.0% | -$0.5M | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||||
| AleAnna, Inc. | Nasdaq: ANNA | Exited | Crude Petroleum & Natural Gas | *W EXP 12/13/202 | 0 | -1,068,400 | -100.0% | -$0.5M | Q3 2026 | 16 Nov 2026 | Q4 2024 | Q2 2026 | 13F, Q2 2026 | ||||
| Nasdaq: KRYS | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -2,000 | -100.0% | -$0.5M | $9.4B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: PGNY | Exited | Services-Misc Health & Allied Services, NEC | COM | 0 | -18,000 | -100.0% | -$0.5M | $2.6B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: TVTX | Exited | Pharmaceutical Preparations | COM | 0 | -12,000 | -100.0% | -$0.5M | $4.6B | Q1 2026 | 15 May 2026 | Q2 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| HEALTHEQUITY, INC. | Nasdaq: HQY | Exited | Services-Business Services, NEC | COM | 0 | -5,000 | -100.0% | -$0.5M | $8.1B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | |||
| Nasdaq: CELC | Exited | Services-Medical Laboratories | COM | 0 | -4,000 | -100.0% | -$0.4M | $2.8B | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| OMEROS CORP | Nasdaq: OMER | Exited | Pharmaceutical Preparations | COM | 0 | -23,000 | -100.0% | -$0.4M | $1.0B | Q1 2026 | 15 May 2026 | Q4 2025 | Q4 2025 | 13F, Q4 2025 | |||
| Sage Therapeutics Inc | Exited | COM | 0 | -42,800 | -100.0% | -$0.4M | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||||
| NYSE: GKOS | Exited | Surgical & Medical Instruments & Apparatus | COM | 0 | -2,600 | -100.0% | -$0.4M | $14.1B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| Nasdaq: IONS | Exited | Pharmaceutical Preparations | COM | 0 | -4,800 | -100.0% | -$0.4M | $4.5B | Q1 2026 | 15 May 2026 | Q3 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Nasdaq: ONC | Exited | Pharmaceutical Preparations | SPONSORED ADS | 0 | -1,100 | -100.0% | -$0.4M | $45.7B | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||
| Nasdaq: LIVN | Exited | Electromedical & Electrotherapeutic Apparatus | SHS | 0 | -6,000 | -100.0% | -$0.4M | $5.1B | Q1 2026 | 15 May 2026 | Q1 2025 | Q4 2025 | 13F, Q4 2025 | ||||
| Blueprint Medicines Corp | Exited | COM | 0 | -4,000 | -100.0% | -$0.4M | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||||
| NYSE: GMED | Exited | Surgical & Medical Instruments & Apparatus | CL A | 0 | -4,000 | -100.0% | -$0.3M | $9.1B | Q1 2026 | 15 May 2026 | Q3 2024 | Q4 2025 | 13F, Q4 2025 | ||||
| Arcellx | Exited | COMMON STOCK | 0 | -4,000 | -100.0% | -$0.3M | Q4 2025 | 17 Feb 2026 | Q3 2024 | Q3 2025 | 13F, Q3 2025 | ||||||
| Nasdaq: MMSI | Exited | Surgical & Medical Instruments & Apparatus | COM | 0 | -3,000 | -100.0% | -$0.3M | $5.1B | Q2 2025 | 14 Aug 2025 | Q3 2024 | Q1 2025 | 13F, Q1 2025 | ||||
| Nasdaq: SRRK | Exited | Biological Products, (No Diagnostic Substances) | COM | 0 | -7,000 | -100.0% | -$0.3M | $6.1B | Q1 2025 | 15 May 2025 | Q4 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| NYSE: HCA | Exited | Services-General Medical & Surgical Hospitals, NEC | COM | 0 | -1,000 | -100.0% | -$0.3M | $96.2B | Q1 2025 | 15 May 2025 | Q3 2024 | Q4 2024 | 13F, Q4 2024 | ||||
| NYSE: COR | Exited | Wholesale-Drugs, Proprietaries & Druggists' Sundries | COM | 0 | -1,000 | -100.0% | -$0.3M | $65.1B | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | ||||
| UNITED THERAPEUTICS Corp | Nasdaq: UTHR | Exited | Pharmaceutical Preparations | COM | 0 | -1,000 | -100.0% | -$0.3M | $23.8B | Q3 2025 | 14 Nov 2025 | Q3 2024 | Q2 2025 | 13F, Q2 2025 | |||
| Nasdaq: SLDP | Exited | Miscellaneous Electrical Machinery, Equipment & Supplies | *W EXP 12/08/202 | 0 | -405,316 | -100.0% | -$0.0M | $344M | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q2 2026 | 13F, Q2 2026 | ||||
| Blue Gold Ltd | Nasdaq: BGL | Exited | Metal Mining | *W EXP 04/01/203 | 0 | -255,800 | -100.0% | -$0.0M | Q3 2026 | 16 Nov 2026 | Q3 2025 | Q2 2026 | 13F, Q2 2026 | ||||
| Exited | COM | 0 | -19,000 | -100.0% | -$0.0M | Q3 2026 | 16 Nov 2026 | Q3 2024 | Q2 2026 | 13F, Q2 2026 |
Alice LuManaging Director · Present
Anna McKayManaging Director · Present
Antenor Camargopartner · Present
Avner HusenPartner · Present
Cameron Hillyerpartner · Present
Colby Trexler Clarkpartner · Present
David T. Kimpartner · Present
Ido KrakowskyManaging Director · Present
Jawad AhmedManaging Director · Present
Joanie LamManaging Director · Present
John FortnerManaging Director · Present
Lyly NguyenManaging Director · Present
Michael G. Linnpartner · Present
Peggy MahonManaging Director · Present
Philip D. Dreyfusspartner · Present
Rafael BarrosoManaging Director · Present
Simone LoewenthalManaging Director · Present
Varun N. Gehanipartner · Present